Mera-med.ru

Онкология
- Лечение онкологии
- Меланома
- Лейкоз
- Острый лейкоз
- Хронический лейкоз
- Лейкоз крови
- Рак



















о лейкозе у человека

The received results testify to statistically significant advantage of mode ТАС in increase безрецидивной and the general{common} survival rate, is especial in subgroups of patients with positive РЭ and РП, and also at involving in process 1-3 axillary лимфоузлов (tab. 1). At the same time, use of mode ТАС was accompanied by the greater гематологической toxicity and the septic complications connected to it{her}, the truth in one group is not marked the lethal outcomes caused by a sepsis. Подробнее...

1491 patient with a cancer has taken part in research BCRIG01 dairy железы with positive axillary лимфоузлами; middle age has made 49 years, 62 % of patients had from 1 up to 3 лимфоузлов, at 69 % of a tumour were рецепторопозитивными on РЭ and РП, at 20 % - positive on HER2/neu. All patients having positive РЭ and РП, received also тамоксифен in a doze of 20 mg / ЯТФ. Within 5 years. The median of time of supervision at the moment of the analysis of results has made 33 (0-49) months. Подробнее...